What We Need to Learn From the Ebola Epidemic
Luckily, the two Americans who received ZMapp, the new experimental drug for Ebola, seem to be improving, which holds great promise and hope for thousands of other people but also raises broader ethical issues and questions.
Robert Klitzman, M.D., ContributorProfessor of Psychiatry and Director of the Masters of Bioethi...